Search

everythinglearnresearchcommunity

for

Search:↓

Bioengineered nanoparticles can effectively treat hair loss by targeting specific enzymes and receptors.

Low iron and vitamin B12 levels are common in women with chronic hair loss, while low vitamin D is less common.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

"Male-pattern" hair loss is common in women, especially after menopause, and doesn't always mean there's a problem with hormone balance.

The treatment combining platelet-rich plasma and a non-cross-linked hyaluronic acid compound significantly improved hair density and reduced bald areas in women with androgenetic alopecia, and it's safe with only mild side effects.

Certain immune cells are more common on the top of the head and might help predict or treat common hair loss.

Patients chose Chinese herbal medicine for safety, relapse prevention, and as an alternative to conventional treatments, but found preparation burdensome.

Some nutritional supplements may help thicken hair in people with hair loss, but taking too much can cause side effects.

PCOS is a hormonal disorder in women that can cause infertility and increases the risk of heart and metabolic issues.

Scalp skin conditions are more common in young adults and teenagers, especially males, with itching being the main complaint. The most common conditions are psoriasis and alopecia areata, and these can significantly affect a person's social life due to their psychological impact.

Using psychological treatments can help manage skin conditions along with regular medical care.

Using multiple treatments together works better for female hair loss than using one treatment alone.

Cicatricial pattern hair loss is likely advanced common baldness, not a type of lichen planopilaris.

Acne not improved by usual treatments may indicate a genetic disorder.

Greater concern about hair loss is linked to more severe hair loss and worse quality of life.

Exosomes from certain stem cells can fight hair loss by promoting hair growth and maintaining the growth phase of hair.

Minoxidil is the only FDA-approved treatment for female hair loss, with other potential treatments needing more research for effectiveness.

COVID-19 may cause a common type of hair loss called telogen effluvium.

Female pattern hair loss is common and should be treated early to prevent worsening, with Minoxidil being the main approved treatment.

Female pattern hair loss is common, worsens with age, and requires long-term treatment to manage.

Pattern hair loss is mainly caused by genetics and hormones, with limited effective treatments available.

Ageing and increased senescent cells significantly contribute to common hair loss.

Hair loss after COVID-19 is common, starts sooner in severe cases, and often comes with scalp pain.

Hair loss after bariatric surgery is common due to nutrient deficiencies and rapid weight loss.

Scalp biopsy helps tell apart permanent and temporary hair loss types and guides treatment.

The study concluded that hirsutism is most common in women aged 14 to 48, often caused by PCOS, and can be effectively treated with Nd YAG laser and IPL.

Wearing a hijab changes the common bacteria and fungi on the scalp, possibly affecting skin health.

Iron deficiency is linked to a common type of hair loss called telogen effluvium.

PCOS is linked to metabolic issues and infertility, needing more research.

Telogen Effluvium (TE) significantly affects women due to stress and hormonal changes, requiring better public health policies and mental health support.